For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
This report studies the Atrial Fibrillation Devices market. Atrial fibrillation (also called AFib or AF) is a quivering or irregular heartbeat (arrhythmia) that can lead to blood clots, stroke, heart failure and other heart-related complications. Atrial Fibrillation Devices are the devices used for atrial fibrillation therapy, including access, diagnostic, visualization and ablation products to assist physicians in diagnosing and treating various irregular heart rhythms.
Scope of the Report:
This report focuses on the Atrial Fibrillation Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
About 4.4% people out of diagnosed atrial fibrillation population are treated using ablation technology in the U.S., Europe, and Japan combined. The atrial fibrillation population treated with ablation is expected to grow with a double digit rate in these regions. The increasing prevalence of atrial fibrillation and advancement in the ablation technologies drive the use of ablation products in the treatment of atrial fibrillation.
This market is segmented, on the basis of surgical procedures, into catheter ablation and surgical ablation. Catheter ablation procedures hold the maximum share in this market and are expected to grow with the highest CAGR during forecast period of 2018 to 2025.
The geographical segmentation includes North America, Europe, Asia-Pacific, South America and Middle East & Africa. North America holds the largest share in this market. However, Asia-Pacific is expected to witness the highest growth rate owing to the presence of a large patient population, growing medical tourism, and high focus of global market players on emerging Asia-Pacific countries such as China and India.
The worldwide market for Atrial Fibrillation Devices is expected to grow at a CAGR of roughly 9.3% over the next five years, will reach 4100 million US$ in 2023, from 2410 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- St. Jude Medical
- Boston Scientific
- Biosense Webster
- Japan Lifeline
- Synaptic Medical
- Osypka AG
- MicroPort Scientific
- Lepu Medical
- APT Med
- TZ Medical
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Catheter Ablation
- Maze Surgery
Market Segment by Applications, can be divided into
- Ambulatory Surgical Centers
There are 15 Chapters to deeply display the global Atrial Fibrillation Devices market.
Chapter 1, to describe Atrial Fibrillation Devices Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Atrial Fibrillation Devices, with sales, revenue, and price of Atrial Fibrillation Devices, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Atrial Fibrillation Devices, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Atrial Fibrillation Devices market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Atrial Fibrillation Devices sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source